I read this Forbes article about 23andMe on the bus this afternoon. It details a perfect instance of the customer as commodity. I'm excited about the possibilities regarding personal genomics, especially as whole-human-genome sequencing gets cheaper and easier to interpret. Control over the resulting data will need to remain in the hands of the consumers, though. Those who volunteer their genetic material for analysis need access to the results.